Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merge Healthcare buys Confirma

This article was originally published in The Gray Sheet

Executive Summary

Health IT provider Merge Healthcare enters the computer-aided detection (CAD) market through its $22 million stock-swap acquisition of Confirma. Under a definitive agreement announced Aug. 6, Merge gains privately-held Confirma's flagship CADstream system, which combines magnetic resonance imaging technology with CAD to detect breast and prostate cancers. CAD technology "is still at an early adoption phase in the market for most indications, but it has significant opportunity as a tool for reducing imaging costs in today's health care reform environment," Merge Healthcare CEO Justin Dearborn explains. Confirma investors will own about 8.5% of Merge after the deal closes in September
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT027793

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel